¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"average count"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±Õ
  • average deviation
    Æò±ÕÆíÂ÷
  • average dose
    1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
  • average life expectancy
    Æò±Õ¿©¸í
  • average movement articulator
    º¸Åë¿îµ¿±³ÇÕ±â
  • moving average
    À̵¿Æò±Õ
  • moving average method
    À̵¿Æò±Õ¹ý
  • automated differential count
    ÀÚµ¿°¨º°°è»ê
  • blood count
    Ç÷±¸°è»ê
  • colony count
    Áý¶ô¼ö, Áý¶ô°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • count
    1. °è»ê 2. °è¼ö
  • differential blood count
    °¨º°Ç÷±¸°è»ê
  • differential count
    °¨º°°è»ê
  • differential leukocyte count
    ¹éÇ÷±¸°¨º°°è¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • count
    °è»ê, ¼ö
  • blood count
    Ç÷±¸°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • radioactivity count
    ¹æ»ç´ÉÃøÁ¤
  • reticulocyte count
    ±×¹°ÀûÇ÷±¸°è»ê, ¼¼¸Á¼¼Æ÷°è»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±Õ
  • average deviation
    Æò±ÕÆíÂ÷
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • average movement articulator
    º¸Åë¿îµ¿±³ÇÕ±â
  • average life expectancy
    Æò±Õ±â´ë¿©¸í
  • moving average
    À̵¿Æò±Õ
  • moving average method
    À̵¿Æò±Õ¹ý
  • automated differential count
    ÀÚµ¿°¨º°°è»ê
  • blood count
    Ç÷±¸°è»ê
  • count
    °è»ê, ¼ö
  • colony count
    Áý¶ô¼ö, Áý¶ô°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • differential count
    °¨º°°è»ê
  • differential blood count
    °¨º°Ç÷±¸°è»ê
  • differential leukocyte count
    °¨º°¹éÇ÷±¸°è»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • CBC =>complete blood count
    ÀüÇ÷±¸°è»ê(Ä¡)
  • plating colony count technique
    ÆòÆÇ¹è¾ç Áý¶ô°è¼ö¹ý
  • radioactivity count
    ¹æ»ç´ÉÃøÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average count
    Æò±Õ¹ø¼ö(ÊÙËÑËà).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±Õ(ÀÇ).
  • average deviation
    Æò±ÕÆíÂ÷(̰˻̰̤).
  • average dose
    Æò±Õ¿ë·®, Æò±ÕÁ¶»ç·®.
  • average expectation of life
    Æò±Õ¿©¸í(̰˻ËçËÎ).
  • average length of life
    Æò±Õ¼ö¸í(̰˻ËÛËÎ).
  • average length of stay
    Æò±Õ Àç¿øÀϼö
  • average molecular weight
    Æò±ÕºÐÀÚ·®.
  • average movement articulator
    º¸Åë ¿îµ¿ ±³ÇÕ±â.
  • average path
    Æò±ÕµµÁ¤(¡­Ô³ïï).
  • average value
    Æò±ÕÄ¡.
  • law of average
    Æò±Õ¹ýÄ¢(̰˻ËÑ̬).
  • moving average
    À̵¿Æò±Õ(ËöËÄ̰˻).
  • moving average method
    À̵¿Æò±Õ¹ý.
  • number of signal average (NSA)
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • time weighted average concentration
    ½Ã°£°¡Á߯ò±Õ³óµµ.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dilution egg count
    Èñ¼®Ãæ¶õ°è»ê
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • count
    °è¼ö(ͪâ¦)
  • plate count
    ÆòÆÇ°è¼ö(øÁ÷ùÌõâ¦)
  • average affinity
    Æò±Õģȭ·Â (øÁгöÑûúÕô)
  • average binding number
    Æò±Õ°áÇÕ¼ö (øÁг̿ùêâ¦)
  • average intrinsic association constant
    Æò±Õ°íÀ¯¿¬ÇÕ»ó¼ö (øÁгͳêóæáùêßÈâ¦)
  • average molecular weight
    Æò±ÕºÐÀÚ·® (øÁгÝÂí­Õá)
  • molecular weight average
    ºÐÀÚ·® Æò±Õ(ÝÂí­ÕáøÁг)
  • number-average molecular weight
    ¹«Æò±ÕºÐÀÚ·®(ÙíøÁгÝÂí­Õá)
  • percentage average deviation
    "ÆÛ¼¾Æ®(¹éºÐÀ²,ÛÝÝÂ×Ë) Æò±ÕÆíÂ÷(øÁгø¶ó¬)"
  • viscosity-average molecular weight
    Á¡µµ(ïÄÓø)Æò±Õ ºÐÀÚ·®(øÁгÝÂí­Õá)
  • weight-average molecular weight
    ¹«°ÔÆò±Õ(øÁг) ºÐÀÚ·®(ÝÂí­Õá)
  • z-average molecular weight
    z Æò±ÕºÐÀÚ·® (øÁгÝÂí­Õá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±ÕÀÇ
  • number of signal average [=NSA]
    ½ÅÈ£Æò±Õȸ¼ö
  • count
    °è¼ö
  • count per minute
    ÀϺа£Ä«¿îÆ®
  • radioactivity count
    ¹æ»ç´É°è¼ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AER abduction/external rotation; acoustic evoked response; acute exertional rhabdomyolysis; agranular en...
AWP airway pressure; any willing provider; average of the wholesale prices; average wholesale price
Isapa spatial average pulse average
Isata spatial average, temporal average intensity [pulse]
SATA spatial average, temporal average
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AAPCC Adjusted Average Per Capita Cost
ARIMA Auto Regressive Integrated Moving Average
ARMA AutoRegressive Moving Average
ADFI Average daily feed intake
ADG Average daily gain
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • average count
    Æò±Õ ¹ø¼ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • average
    Æò±Õ, Æò±ÕÀÇ
  • average dose
    Æò±Õ ¿ë·®, Æò±Õ Á¶»ç·®
  • average length of life
    Æò±Õ ¼ö¸í
  • average maintenance dose
    µð±âÅ»¸®½º Æò±Õ À¯Áö·®
  • average molecular weight
    Æò±Õ ºÐÀÚ·®
  • average value
    Æò±ÕÄ¡
  • number of signal average
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • time weighted average concentration
    ½Ã°£ °¡Áß Æò±Õ ³óµµ
  • blood count
    Ç÷±¸°è»ê
    ÀÏÁ¤ÀÇ Ç÷¾×·® 1§§Áß À¯Çü ¼ººÐ¼öÀÇ ÃøÁ¤.
  • cell count
    ¼¼Æ÷ ¼ö
    ´ÜÀ§ ºÎÇÇ´ç Æ÷ÇԵǾî ÀÖ´Â ¼¼Æ÷ ¼ö·Î¼­ º¸Åë ´ÜÀ§ ºÎÇÇ´ç Ç÷¾×¿¡ Æ÷ÇԵǾî ÀÖ´Â ÀûÇ÷±¸¿Í/ȤÀº ¹éÇ÷±¸¸¦ ¸»ÇÑ´Ù.
  • complete blood count
    ÀüÇ÷ °Ë»ç, ÀüÇ÷±¸ °è»ê
  • corrected reticulocyte count
    ?
  • count per minute
    ÀϺа£ Ä«¿îÆ®
  • dust count
    ¸ÕÁö °è»ê¹ý
  • full blood count
    ÀüÇ÷ ÃøÁ¤, Ç÷¾× ÃÑ·® ¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
average <statistics> A value that represents the sum of values divided by the number of values in the set. It represents or summarises the relevant features of a set of values.
Origin: M.E. Averays, loss from damage to ship or cargo, fr. It. Avaris, fr. Ar. 'awariya, damaged goods, + damage
(05 Mar 2000)
average flow rate <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute.
(05 Mar 2000)
average megawatt <physics> One megawatt of capacity produced continuously over a period of one year. 1 MWa = 1 MW x 8760 hours/year = 8,760 Mwh = 8,760,000 kWh.
Acronym: MWa
(05 Dec 1998)
average pulse magnitude <physics> The amplitude of pulse averaged throughout its duration; identical with peak amplitude for a square wave or pulse without droop.
(05 Mar 2000)
law of average localization Visceral pain is most accurately localised in the least mobile viscera and least accurately in the most mobile.
(05 Mar 2000)
absolute CD4 count The number of helper T-lymphocytes in a cubic millimeter of blood. With HIV, the absolute CD4 count declines as the infection progresses. The absolute CD4 count is frequently used to monitor the extent of immune suppression in persons with HIV. Also called a T4 count.
(12 Dec 1998)
absolute eosinophil count <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen.
This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre).
(27 Sep 1997)
Addis count A quantitative enumeration of the red blood count, white blood count, and casts in a 12-hr urine specimen; used to follow the progress of known renal disease.
(05 Mar 2000)
Arneth count The percentage distribution of polymorphonuclear neutrophils, based on the number of lobes in the nuclei (from 1 to 5).
See: Arneth index.
(05 Mar 2000)
b and t cell count A test that measures the respective quantities of B lymphocytes and T lymphocytes. This test is often performed in the analysis of an immune deficiency disorder. Normal values include: 68 to 75% of total lymphocytes are T lymphocytes and 10 to 20% are B lymphocytes.
Increased T-cell counts can indicate infectious mononucleosis, acute lymphocytic leukaemia or multiple myeloma.
Increased B lymphocytes can indicate chronic lymphocytic leukaemia, multiple myeloma, Waldenstrom's macroglobulinaemia or Di George syndrome. Decreased T-cells may indicate congenital T-cell deficiency, Wiskott-Aldrich syndrome or AIDS. Decreased B-cells may indicate acute lymphocytic leukaemia or a congenital immunoglobulin deficiency disorder.
(27 Sep 1997)
blood cell count A count of the number of leukocytes and erythrocytes per unit volume in a sample of venous blood. A complete blood count (cbc) also includes measurement of the haemoglobin, haematocrit, and erythrocyte indices.
(12 Dec 1998)
blood count <haematology, investigation> The determination of the proper number of red blood cells, white blood cells and platelets are present in the patients blood.
Acronym: FBC
(16 Dec 1997)
red blood cell count A normal value is 4.6-6.2 million RBC's per cubic millimetre of blood. This number can increase in cases of dehydration (fluid loss) or severe lung disease. Interestingly, red blood cell counts are much higher in those who live at high altitude, because of the increased demand for oxygen carrying capacity.
(27 Sep 1997)
viable cell count Number of cells in a given area or volume that are thriving.
(05 Mar 2000)
viable count Measurement of the concentration of live cells in a microbial population.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±Õ,Æò±ÕÀÇ,º¸ÅëÀÇ,Æò±ÕÇÏ´Ù
  • DowJones average
    (Áõ±Ç)´Ù¿ì Á¸½º Æò±Õ(ÁÖ°¡)
  • DowJones industrial average
    ´Ù¿ì Á¸½º °ø¾÷ÁÖ(ÁÖ) Æò±Õ
  • average
    Æò±ÕÀÇ;Ç¥ÁØÀÇ;º¸ÅëÀÇ;ÇØ¼Õ-Æò±ÕÇÏ´Ù;Æò±Õ ...ÀÌ µÇ´Ù;(Áõ±Ç µûÀ§¸¦ ¸Å¸ÅÇÏ¿©)Æò±Õ°ªÀ» ³»¸®´Ù
  • earned run average
    (¾ß±¸)(Åõ¼öÀÇ)¹æ¾îÀ²
  • fielding average
    ¼öºñÀ²
  • general average
    °øµ¿ ÇØ¼Õ
  • grade point average
    (¹Ì)¼ºÀûÀÇ Æò±ÕÁ¡
  • gross average
    °øµ¿ ÇØ¼Õ
  • particular average
    ´Üµ¶ ÇØ¼Õ
  • petty average
    »ç¼ÒÇÑ ÇØ¼Õ
  • count
    ¼¼´Ù,°è»êÇÏ´Ù
  • count for
    Áß¿äÇÏ´Ù
  • count in
    ¼À¿¡ ³Ö´Ù; ÇÑÆÐ¿¡ ³¢¿öÁÖ´Ù
  • count on
    ÀÇÁöÇÏ´Ù; ¹Ï´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á